Michel Wyndaele1, Chendrimada Madhu2, Hashim Hashim3. 1. Department of Urology, University Medical Center Utrecht, Utrecht, Belgium. 2. Department of Urogynaecology, Southmead Hospital, Bristol, United Kingdom. 3. Bristol Urological Institute, Southmead Hospital, Bristol, United Kingdom.
Abstract
OBJECTIVE: To evaluate the trends in female stress urinary incontinence (SUI) surgery in a UK tertiary referral center during five years before the July 2018 tape suspension and to compare it with National Health Service (NHS) England data. MATERIALS AND METHODS: A retrospective study of female SUI procedures (bulking agents, mid-urethral sling [MUS], colposuspension, autologous fascial sling) in a single UK tertiary referral center between 2013 and 2018. The treatment choice was made through shared decision-making on the basis of national standardized information leaflets, patient's own research, and discussion/clarification with the surgeon. Data on NHS England SUI surgery between 2012 and 2018 were extracted from a retrospective review of the hospital episode statistics. RESULTS: Between 2013 and 2018, 448 procedures for SUI were performed at our center. In contrast to a significant 31% decline in the total number of SUI procedures in NHS England in that time period, no decline in the number of SUI procedures occurred in our center. However, the distribution of SUI procedures did change significantly. MUS procedures declined significantly (46% total and 45% relative), whereas bulking agents and colposuspensions showed a clear relative rise (+11% and +30%). The distribution of SUI procedures in NHS England also changed significantly with a decline in MUS procedures (39% total and 11% relative) and an increase in bulking agents (82% total and 9% relative). CONCLUSION: When all invasive treatment options are transparently presented to female patients with SUI, they prefer other surgical treatments as an alternative to MUS.
OBJECTIVE: To evaluate the trends in female stress urinary incontinence (SUI) surgery in a UK tertiary referral center during five years before the July 2018 tape suspension and to compare it with National Health Service (NHS) England data. MATERIALS AND METHODS: A retrospective study of female SUI procedures (bulking agents, mid-urethral sling [MUS], colposuspension, autologous fascial sling) in a single UK tertiary referral center between 2013 and 2018. The treatment choice was made through shared decision-making on the basis of national standardized information leaflets, patient's own research, and discussion/clarification with the surgeon. Data on NHS England SUI surgery between 2012 and 2018 were extracted from a retrospective review of the hospital episode statistics. RESULTS: Between 2013 and 2018, 448 procedures for SUI were performed at our center. In contrast to a significant 31% decline in the total number of SUI procedures in NHS England in that time period, no decline in the number of SUI procedures occurred in our center. However, the distribution of SUI procedures did change significantly. MUS procedures declined significantly (46% total and 45% relative), whereas bulking agents and colposuspensions showed a clear relative rise (+11% and +30%). The distribution of SUI procedures in NHS England also changed significantly with a decline in MUS procedures (39% total and 11% relative) and an increase in bulking agents (82% total and 9% relative). CONCLUSION: When all invasive treatment options are transparently presented to female patients with SUI, they prefer other surgical treatments as an alternative to MUS.
Authors: Vivienne Kirchin; Tobias Page; Phil E Keegan; Kofi Om Atiemo; June D Cody; Samuel McClinton; Patricia Aluko Journal: Cochrane Database Syst Rev Date: 2017-07-25
Authors: Colby P Souders; Karyn S Eilber; Lynn McClelland; Lauren N Wood; Alexander R Souders; Vicki Steiner; Jennifer Tash Anger Journal: Female Pelvic Med Reconstr Surg Date: 2018 Jan/Feb Impact factor: 2.091
Authors: Julien Labrie; Bary L C M Berghmans; Kathelijn Fischer; Alfredo L Milani; Ileana van der Wijk; Dina J C Smalbraak; Astrid Vollebregt; René P Schellart; Giuseppe C M Graziosi; J Marinus van der Ploeg; Joseph F G M Brouns; E Stella M Tiersma; Annette G Groenendijk; Piet Scholten; Ben Willem Mol; Elisabeth E Blokhuis; Albert H Adriaanse; Aaltje Schram; Jan-Paul W R Roovers; Antoine L M Lagro-Janssen; Carl H van der Vaart Journal: N Engl J Med Date: 2013-09-19 Impact factor: 91.245
Authors: Goran Rac; Austin Younger; James Q Clemens; Kathleen Kobashi; Aqsa Khan; Victor Nitti; Ilana Jacobs; Gary E Lemack; Elizabeth T Brown; Roger Dmochowski; Lara MacLachlan; Arthur Mourtzinos; David Ginsberg; Michelle Koski; Ross Rames; Eric S Rovner Journal: Neurourol Urodyn Date: 2016-07-26 Impact factor: 2.696
Authors: Zainab A Khan; Arjun Nambiar; Roland Morley; Christopher R Chapple; Simon J Emery; Malcolm G Lucas Journal: BJU Int Date: 2014-10-22 Impact factor: 5.588